263 related articles for article (PubMed ID: 17065350)
21. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
[TBL] [Abstract][Full Text] [Related]
22. Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
Kim CS; Sohn EJ; Kim YS; Jung DH; Jang DS; Lee YM; Kim DH; Kim JS
J Ethnopharmacol; 2007 May; 111(2):240-7. PubMed ID: 17194556
[TBL] [Abstract][Full Text] [Related]
23. Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
Kondo T; Takemura G; Kosai K; Ohno T; Takahashi T; Esaki M; Goto K; Maruyama R; Murata I; Minatoguchi S; Fujiwara T; Fujiwara H
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1288-93. PubMed ID: 18505441
[TBL] [Abstract][Full Text] [Related]
24. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
Hamada Y; Fukagawa M
Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205
[TBL] [Abstract][Full Text] [Related]
25. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
26. Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats.
Nakamaki S; Satoh H; Kudoh A; Hayashi Y; Hirai H; Watanabe T
Exp Biol Med (Maywood); 2011 May; 236(5):614-20. PubMed ID: 21521713
[TBL] [Abstract][Full Text] [Related]
27. Diabetic nephropathy: where hemodynamics meets metabolism.
Forbes JM; Fukami K; Cooper ME
Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
[TBL] [Abstract][Full Text] [Related]
28. Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN.
Mahimainathan L; Das F; Venkatesan B; Choudhury GG
Diabetes; 2006 Jul; 55(7):2115-25. PubMed ID: 16804083
[TBL] [Abstract][Full Text] [Related]
29. The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice.
Xu S; Jiang B; Maitland KA; Bayat H; Gu J; Nadler JL; Corda S; Lavielle G; Verbeuren TJ; Zuccollo A; Cohen RA
Diabetes; 2006 Jan; 55(1):110-9. PubMed ID: 16380483
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of Gui Qi mixture on the progression of diabetic nephropathy in rats.
Zhang YW; Xie D; Chen YX; Zhang HY; Xia ZX
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):563-8. PubMed ID: 17177138
[TBL] [Abstract][Full Text] [Related]
31. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage.
Ho EC; Lam KS; Chen YS; Yip JC; Arvindakshan M; Yamagishi S; Yagihashi S; Oates PJ; Ellery CA; Chung SS; Chung SK
Diabetes; 2006 Jul; 55(7):1946-53. PubMed ID: 16804062
[TBL] [Abstract][Full Text] [Related]
32. Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress.
Zhang M; Hagiwara S; Matsumoto M; Gu L; Tanimoto M; Nakamura S; Kaneko S; Gohda T; Qian J; Horikoshi S; Tomino Y
Metabolism; 2006 Dec; 55(12):1590-8. PubMed ID: 17142129
[TBL] [Abstract][Full Text] [Related]
33. Deletion of MK2 signalling in vivo inhibits small Hsp phosphorylation but not diabetic nephropathy.
Park JK; Ronkina N; Höft A; Prohl C; Menne J; Gaestel M; Haller H; Meier M
Nephrol Dial Transplant; 2008 Jun; 23(6):1844-53. PubMed ID: 18182404
[TBL] [Abstract][Full Text] [Related]
34. Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism.
Sällström J; Carlsson PO; Fredholm BB; Larsson E; Persson AE; Palm F
Acta Physiol (Oxf); 2007 Jul; 190(3):253-9. PubMed ID: 17581137
[TBL] [Abstract][Full Text] [Related]
35. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
[TBL] [Abstract][Full Text] [Related]
36. Evalution of oxidative stress in diabetic animals by in vivo electron spin resonance measurement--role of protein kinase C.
Sonta T; Inoguchi T; Tsubouchi H; Sekiguchi N; Kobayashi K; Matsumoto S; Utsumi H; Nawata H
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S109-13. PubMed ID: 15563958
[TBL] [Abstract][Full Text] [Related]
37. Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats.
Zhang YW; Xie D; Xia B; Zhen RT; Liu IM; Cheng JT
Horm Metab Res; 2006 Feb; 38(2):82-8. PubMed ID: 16523407
[TBL] [Abstract][Full Text] [Related]
38. Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy.
Tan Y; Keum JS; Wang B; McHenry MB; Lipsitz SR; Jaffa AA
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1026-35. PubMed ID: 17596525
[TBL] [Abstract][Full Text] [Related]
39. Renoprotective antioxidant effect of alagebrium in experimental diabetes.
Park J; Kwon MK; Huh JY; Choi WJ; Jeong LS; Nagai R; Kim WY; Kim J; Lee GT; Lee HB; Ha H
Nephrol Dial Transplant; 2011 Nov; 26(11):3474-84. PubMed ID: 21478303
[TBL] [Abstract][Full Text] [Related]
40. Protein kinase C-beta inhibition attenuates the progression of nephropathy in non-diabetic kidney disease.
Kelly DJ; Edgley AJ; Zhang Y; Thai K; Tan SM; Cox AJ; Advani A; Connelly KA; Whiteside CI; Gilbert RE
Nephrol Dial Transplant; 2009 Jun; 24(6):1782-90. PubMed ID: 19155535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]